Endoscopic Versus Conventional Lumbar Decompression for Lumbar Canal Stenosis (ENDOLSS)
Outcomes Evaluation of Interlaminar Endoscopic Uniportal Bilateral Lumbar Decompression Versus Open Laminectomy for Degenerative Lumbar Canal Stenosis
調査の概要
状態
条件
詳細な説明
This randomized controlled trial was designed to compare the clinical and surgical outcomes of interlaminar uniportal endoscopic bilateral lumbar decompression versus conventional open laminectomy in patients diagnosed with degenerative lumbar canal stenosis. Lumbar spinal stenosis is a common degenerative condition that results in neurogenic claudication, radicular pain, and functional disability due to compression of neural elements.
The study was conducted at Ain Shams University Hospitals and Damanhour Medical National Institute. Patients meeting inclusion criteria were diagnosed based on clinical evaluation and radiological confirmation using MRI. Eligible patients were randomized into two groups: one group underwent minimally invasive interlaminar uniportal endoscopic bilateral decompression, while the other group underwent conventional open laminectomy.
The primary objective of the study was to compare the effectiveness of both surgical techniques in terms of pain relief and functional improvement. Secondary objectives included comparison of operative time, intraoperative blood loss, postoperative hospital stay, complication rates, muscle injury markers, and time to return to normal activity.
Patients were evaluated preoperatively and postoperatively using standardized clinical assessment tools. Postoperative follow-up was conducted at one day postoperative period, one month, and six months to assess both early and mid-term outcomes.
The hypothesis of the study is that minimally invasive endoscopic decompression provides equivalent or superior clinical outcomes compared to conventional open laminectomy, with the advantage of reduced tissue trauma, less postoperative pain, faster recovery, and shorter hospital stay.
This study aims to contribute to the growing evidence supporting minimally invasive spine surgery techniques and to provide high-quality comparative data to guide surgical decision-making in degenerative lumbar canal stenosis.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Cairo、エジプト
- Ain shams university hospitals
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Patients diagnosed with degenerative lumbar spinal stenosis based on clinical and radiological findings.
Patients presenting with neurogenic claudication and/or radicular leg pain. Patients indicated for surgical decompression after failure of conservative treatment.
Age 18 years and above. Patients able to provide informed consent.
Exclusion Criteria:
Patients with previous lumbar spine surgery at the same level. Patients with spinal instability requiring fusion. Presence of spinal infection, tumor, or traumatic pathology. Severe comorbid conditions contraindicating surgery. Patients with incomplete clinical or follow-up data.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Endoscopic Decompression Group
Patients undergo interlaminar uniportal endoscopic bilateral lumbar decompression for treatment of degenerative lumbar spinal stenosis.
|
Minimally invasive interlaminar uniportal endoscopic decompression of the lumbar spinal canal performed for treatment of degenerative lumbar spinal stenosis.
The procedure aims to relieve neural compression while preserving posterior spinal structures and reducing tissue trauma compared to open surgery.
他の名前：
|
|
アクティブコンパレータ：Open Laminectomy Group
Patients undergo conventional open laminectomy for treatment of degenerative lumbar spinal stenosis
|
Standard open lumbar laminectomy performed for decompression of the spinal canal in patients with degenerative lumbar spinal stenosis.
The procedure involves removal of posterior bony and ligamentous structures to relieve neural compression.
他の名前：
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Functional Disability (Oswestry Disability Index - ODI)
時間枠：Preoperative, 1 month, and 6 months postoperative
|
The Oswestry Disability Index (ODI) will be used to evaluate functional disability related to lumbar spinal stenosis.
The ODI is a validated questionnaire assessing limitations in activities of daily living, including pain intensity, personal care, walking, sitting, standing, and social function.
Scores range from 0 to 100, with higher scores indicating greater disability.
Outcomes will be compared between patients undergoing interlaminar endoscopic and conventional open lumbar decompression.
|
Preoperative, 1 month, and 6 months postoperative
|
|
Postoperative Leg Pain (VAS-Leg Score)
時間枠：Preoperative, 1 day, 1 month, and 6 months postoperative
|
Radicular leg pain will be assessed using the Visual Analogue Scale (VAS), a validated 10-point scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Patients will rate their leg pain intensity preoperatively and at follow-up intervals.
This measure reflects the severity of nerve root compression symptoms and will be used to compare the effectiveness of interlaminar endoscopic versus conventional open lumbar decompression
|
Preoperative, 1 day, 1 month, and 6 months postoperative
|
|
Postoperative Back Pain (VAS-Back Score)
時間枠：Preoperative, 1 day, 1 month, and 6 months postoperative
|
Low back pain intensity will be assessed using the Visual Analogue Scale (VAS), a validated patient-reported outcome measure ranging from 0 (no pain) to 10 (worst imaginable pain).
This scale evaluates the severity of axial back pain associated with degenerative lumbar spinal stenosis.
Measurements will be obtained preoperatively and at follow-up intervals to compare pain relief between interlaminar endoscopic and conventional open lumbar decompression techniques.
|
Preoperative, 1 day, 1 month, and 6 months postoperative
|
|
Claudication Distance
時間枠：Preoperative, 1 month, and 6 months postoperative
|
Claudication distance will be assessed as the maximum walking distance a patient can achieve before the onset of neurogenic claudication symptoms, such as leg pain, numbness, or weakness.
This measure reflects functional limitation due to lumbar spinal stenosis and will be used to evaluate improvement after interlaminar endoscopic versus open lumbar decompression.
|
Preoperative, 1 month, and 6 months postoperative
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Operative Time
時間枠：Intraoperative
|
Duration of surgery measured in hours from skin incision to wound closure in patients undergoing endoscopic versus open lumbar decompression.
|
Intraoperative
|
|
Length of Hospital Stay
時間枠：From surgery to hospital discharge (typically within 1-5 days postoperative)
|
Duration of hospitalization measured in days from surgery to discharge.
|
From surgery to hospital discharge (typically within 1-5 days postoperative)
|
|
Postoperative Complications
時間枠：Up to 6 months postoperative
|
Incidence of postoperative complications including infection, dural tear, neurological deficit, and reoperation.
|
Up to 6 months postoperative
|
|
Time to Return to Work
時間枠：Up to 6 months postoperative
|
Time taken for patients to resume normal daily activities or return to work after surgery.
|
Up to 6 months postoperative
|
|
Creatine Phosphokinase (CPK) Level
時間枠：1 day postoperative
|
Serum creatine phosphokinase (CPK) levels will be measured as a biomarker of muscle injury associated with surgical intervention.
Levels will be compared between endoscopic and open lumbar decompression groups to assess the degree of muscle damage.
|
1 day postoperative
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Mohammad Yousof Aboukila, MD、Ain Shams University, Faculty of Medicine, Department of Neurosurgery
出版物と役立つリンク
一般刊行物
- Aboukila MY, et al. "Outcomes Evaluation of Interlaminar Endoscopic Uniportal Bilateral Lumbar Decompression versus Open Laminectomy for Degenerative Lumbar Canal Stenosis." Ain Shams University, Department of Neurosurgery, 2026. (Unpublished clinical study / thesis)
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- FMASU MD323/2023
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。